{"url_path":"/sec/cik-0001900520/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1900520/0001213900-26-057605-index.html","accession_number":"0001213900-26-057605","cik":"0001900520","ticker":null,"issuer_name":"Lomond Therapeutics Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1900520/0001213900-26-057605-index.html","primary_entity_key":"0001900520","primary_entity_name":"Lomond Therapeutics Holdings, Inc."},"word_count":137,"has_tables":true,"body_markdown":"**Item 1A. Risk Factors**\n\n \n\nPlease carefully consider the information set\nforth in this Quarterly Report on Form 10-Q and the risk factors discussed in Part I, “Item 1A. Risk Factors” in our Annual\nReport. The risks described in our Annual Report, as well as other risks and uncertainties, could materially and adversely affect our\nbusiness, results of operations, and financial condition, which in turn could materially and adversely affect the trading price of shares\nof our common stock. The occurrence of any of the risks discussed in such filings, or other events that we do not currently anticipate\nor that we currently deem immaterial, could harm our business, prospects, financial condition and results of operations. In that case,\nthe trading price of our common stock could decline, and you may lose all or part of your investment."}